UBS Group’s TriSalus Life Sciences TLSI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $91K | Buy |
16,692
+9,883
| +145% | +$53.9K | ﹤0.01% | 6050 |
|
|
2025
Q1 | $37.6K | Buy |
6,809
+6,787
| +30,850% | +$37.5K | ﹤0.01% | 6498 |
|
|
2024
Q4 | $110 | Hold |
22
| – | – | ﹤0.01% | 8392 |
|
|
2024
Q3 | $101 | Sell |
22
-1,966
| -99% | -$9.03K | ﹤0.01% | 7941 |
|
|
2024
Q2 | $11K | Buy |
1,988
+1,597
| +408% | +$8.82K | ﹤0.01% | 6512 |
|
|
2024
Q1 | $3.81K | Sell |
391
-16,424
| -98% | -$160K | ﹤0.01% | 6523 |
|
|
2023
Q4 | $142K | Sell |
16,815
-8,117
| -33% | -$68.6K | ﹤0.01% | 4796 |
|
|
2023
Q3 | $128K | Buy |
24,932
+24,910
| +113,227% | +$128K | ﹤0.01% | 4566 |
|
|
2023
Q2 | $231 | Sell |
22
-90
| -80% | -$945 | ﹤0.01% | 7277 |
|
|
2023
Q1 | $1.15K | Sell |
112
-1,947
| -95% | -$19.9K | ﹤0.01% | 7698 |
|
|
2022
Q4 | $20.7K | Buy |
2,059
+2,037
| +9,259% | +$20.4K | ﹤0.01% | 6442 |
|
|
2022
Q3 | $0 | Sell |
22
-24,795
| -100% | – | ﹤0.01% | 9686 |
|
|
2022
Q2 | $244K | Buy |
24,817
+24,694
| +20,076% | +$243K | ﹤0.01% | 3802 |
|
|
2022
Q1 | $1K | Sell |
123
-1,329
| -92% | -$10.8K | ﹤0.01% | 8870 |
|
|
2021
Q4 | $14K | Buy |
1,452
+1,446
| +24,100% | +$13.9K | ﹤0.01% | 7232 |
|
|
2021
Q3 | $0 | Sell |
6
-1,143
| -99% | – | ﹤0.01% | 8777 |
|
|
2021
Q2 | $11K | Buy |
1,149
+1,132
| +6,659% | +$10.8K | ﹤0.01% | 6876 |
|
|
2021
Q1 | $0 | Buy |
+17
| New | – | ﹤0.01% | 8224 |
|